Exact Mass: 542.3104192000001
Exact Mass Matches: 542.3104192000001
Found 60 metabolites which its exact mass value is equals to given mass value 542.3104192000001
,
within given mass tolerance error 0.01 dalton. Try search metabolite list with more accurate mass tolerance error
0.001 dalton.
Belladonnine
A - Alimentary tract and metabolism > A03 - Drugs for functional gastrointestinal disorders > A03B - Belladonna and derivatives, plain > A03BA - Belladonna alkaloids, tertiary amines
PL
Pl, also known as ddaxhpp-ii, is a member of the class of compounds known as macrolides and analogues. Macrolides and analogues are organic compounds containing a lactone ring of at least twelve members. Pl is practically insoluble (in water) and a very weakly acidic compound (based on its pKa). Pl can be found in cucumber, which makes pl a potential biomarker for the consumption of this food product. PL, P.L., Pl, or .pl may refer to: .
C29H42N4O6_5-Carbamimidamido-2-(4,6-dihydroxy-2,5,5,8a-tetramethyl-6-oxo-3,4,4a,5,6,6,7,8,8,8a-decahydro-2H-spiro[furo[2,3-e]isoindole-2,1-naphthalen]-7(3H)-yl)pentanoic acid
C29H42N4O6 (542.3104192000001)
2,3-dihydroxypropyl [3-[(4Z,7Z,10Z,13Z,16Z,19Z)-docosa-4,7,10,13,16,19-hexaenoxy]-2-hydroxypropyl] hydrogen phosphate
[1-propanoyloxy-3-[3,4,5-trihydroxy-6-(hydroxymethyl)oxan-2-yl]oxypropan-2-yl] (7Z,10Z,13Z)-hexadeca-7,10,13-trienoate
(1-phosphonooxy-3-propanoyloxypropan-2-yl) (10Z,13Z,16Z,19Z)-docosa-10,13,16,19-tetraenoate
(1-nonanoyloxy-3-phosphonooxypropan-2-yl) (4Z,7Z,10Z,13Z)-hexadeca-4,7,10,13-tetraenoate
(1-heptanoyloxy-3-phosphonooxypropan-2-yl) (6Z,9Z,12Z,15Z)-octadeca-6,9,12,15-tetraenoate
(1-pentanoyloxy-3-phosphonooxypropan-2-yl) (8Z,11Z,14Z,17Z)-icosa-8,11,14,17-tetraenoate
Histamine H4 receptor antagonist-1
Histamine H4 receptor antagonist-1 is an antagonist of histamine H4 receptor extracted from patent WO2010108059A1 compound 60[1].
1,4-bis({8-methyl-8-azabicyclo[3.2.1]octan-3-yl}) (4r)-1-phenyl-3,4-dihydro-2h-naphthalene-1,4-dicarboxylate
[3,4,5-trihydroxy-6-({4-[5-hydroxy-3-(hydroxymethyl)pent-3-en-1-yl]-8-(hydroxymethyl)-3,4,8a-trimethyl-1,2,3,4a,5,6-hexahydronaphthalen-1-yl}oxy)oxan-2-yl]methyl acetate
(3s,3ar,4s,6as,10s,13r,14s,17ar)-4-ethyl-1,13,14-trihydroxy-3-[(1r)-1-(1h-indol-3-yl)ethyl]-5,10,12-trimethyl-3h,3ah,4h,6ah,9h,10h,13h,14h-cyclotrideca[d]isoindol-17-one
4,12-bis(acetyloxy)-3,5,13-trihydroxy-6-isopropyl-3,9,13-trimethyl-15-oxatricyclo[6.6.1.0²,⁷]pentadecan-9-yl butanoate
(1r,2s,3s,4r,5s,6r,7r,8r,9r,12s,13s)-4,5-bis(acetyloxy)-3,12,13-trihydroxy-6-isopropyl-3,9,13-trimethyl-15-oxatricyclo[6.6.1.0²,⁷]pentadecan-9-yl butanoate
14-hydroxy-5-(hydroxymethyl)-5,9-dimethyl-14-({[3,4,5-trihydroxy-6-(hydroxymethyl)oxan-2-yl]oxy}methyl)tetracyclo[11.2.1.0¹,¹⁰.0⁴,⁹]hexadecan-15-yl acetate
(1r,2s,3s,4r,5s,6r,7r,8r,9s,12s,13s)-4,5-bis(acetyloxy)-3,12,13-trihydroxy-6-isopropyl-3,9,13-trimethyl-15-oxatricyclo[6.6.1.0²,⁷]pentadecan-9-yl butanoate
(1r,2s,3s,4r,5s,6r,7r,8r,9r,12s,13s)-4,12-bis(acetyloxy)-3,5,13-trihydroxy-6-isopropyl-3,9,13-trimethyl-15-oxatricyclo[6.6.1.0²,⁷]pentadecan-9-yl butanoate
6,14-dihydroxy-5,5,9-trimethyl-14-({[3,4,5-trihydroxy-6-(hydroxymethyl)oxan-2-yl]oxy}methyl)tetracyclo[11.2.1.0¹,¹⁰.0⁴,⁹]hexadecan-15-yl acetate
9-benzoyl-11-(3,7-dimethylocta-2,6-dien-1-yl)-4,4,8,8-tetramethyltetracyclo[7.3.1.1⁷,¹¹.0¹,⁵]tetradecane-3,10,12,13-tetrone
(1s,4r,6s,9s,10r,13s,14s,15s)-6,14-dihydroxy-5,5,9-trimethyl-14-({[(2s,3s,4r,5s,6s)-3,4,5-trihydroxy-6-(hydroxymethyl)oxan-2-yl]oxy}methyl)tetracyclo[11.2.1.0¹,¹⁰.0⁴,⁹]hexadecan-15-yl acetate
(3s,6s,9r,12s,16r)-5,8,11,14-tetrahydroxy-3,6,12-triisopropyl-9-methyl-16-[(1e)-2-phenylethenyl]-1-oxa-4,7,10,13-tetraazacyclohexadeca-4,7,10,13-tetraen-2-one
C29H42N4O6 (542.3104192000001)
1,4-bis[(1r,3s,5s)-8-methyl-8-azabicyclo[3.2.1]octan-3-yl] (1s,4s)-1-phenyl-3,4-dihydro-2h-naphthalene-1,4-dicarboxylate
[(2s,3r,4r,5r,6r)-6-{[(1r,3s,4s,4ar,8ar)-4-[(3z)-5-hydroxy-3-(hydroxymethyl)pent-3-en-1-yl]-8-(hydroxymethyl)-3,4,8a-trimethyl-1,2,3,4a,5,6-hexahydronaphthalen-1-yl]oxy}-3,4,5-trihydroxyoxan-2-yl]methyl acetate
5,8,11,14-tetrahydroxy-3,6,12-triisopropyl-9-methyl-16-(2-phenylethenyl)-1-oxa-4,7,10,13-tetraazacyclohexadeca-4,7,10,13-tetraen-2-one
C29H42N4O6 (542.3104192000001)
4,5-bis(acetyloxy)-3,12,13-trihydroxy-6-isopropyl-3,9,13-trimethyl-15-oxatricyclo[6.6.1.0²,⁷]pentadecan-9-yl butanoate
(1r,4s,5r,9r,10s,13r,14r,15r)-14-hydroxy-5-(hydroxymethyl)-5,9-dimethyl-14-({[(2r,3r,4s,5s,6r)-3,4,5-trihydroxy-6-(hydroxymethyl)oxan-2-yl]oxy}methyl)tetracyclo[11.2.1.0¹,¹⁰.0⁴,⁹]hexadecan-15-yl acetate
(1s,5s,7r,9s,11r)-9-benzoyl-11-[(2e)-3,7-dimethylocta-2,6-dien-1-yl]-4,4,8,8-tetramethyltetracyclo[7.3.1.1⁷,¹¹.0¹,⁵]tetradecane-3,10,12,13-tetrone
9-benzyl-6-ethyl-1,4,7-trihydroxy-3-(7-hydroxy-6-oxooctyl)-6-methyl-3h,9h,12h,13h,14h,14ah-pyrrolo[1,2-a]1,4,7,10-tetraazacyclododecan-10-one
C29H42N4O6 (542.3104192000001)
1,4-bis({8-methyl-8-azabicyclo[3.2.1]octan-3-yl}) (4s)-1-phenyl-3,4-dihydro-2h-naphthalene-1,4-dicarboxylate
[(2r,3s,4s,5r,6r)-6-{[(1s,3r,4s,4ar,8ar)-4-[(3z)-5-hydroxy-3-(hydroxymethyl)pent-3-en-1-yl]-8-(hydroxymethyl)-3,4,8a-trimethyl-1,2,3,4a,5,6-hexahydronaphthalen-1-yl]oxy}-3,4,5-trihydroxyoxan-2-yl]methyl acetate
(2s)-5-carbamimidamido-2-[(2s,3s)-2-(4,8-dimethylnona-3,7-dien-1-yl)-3,5-dihydroxy-2-methyl-7-oxo-3h,4h,9h-pyrano[2,3-e]isoindol-8-yl]pentanoic acid
C29H42N4O6 (542.3104192000001)